Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum.
Despite physiological evidence that cholecystokinin (CCK) is an excitatory neurotransmitter in the brain, little is known about its mechanism of action. CCK immunoreactivity in the brain, including projections to the striatum, is primarily attributable to the sulfated octapeptide CCK-8S. We report here that CCK-8S abolishes cAMP-dependent phosphorylation of a dopamine- and cAMP-regulated 32-kDa phosphoprotein (DARPP-32) in striatal neurons. The effect of CCK-8S is prevented by antagonists of CCKB and N-methyl-D-aspartate receptors. Our results support a model in which CCK-8S, originating from CCK or CCK/glutamate corticostriatal neurons, promotes the release of an excitatory neurotransmitter that causes the dephosphorylation and inactivation of DARPP-32, a potent protein phosphatase inhibitor, thereby modulating neuronal excitability.
Snyder
G L
GL
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, NY 10021.
Fisone
G
G
Morino
P
P
Gundersen
V
V
Ottersen
O P
OP
Hökfelt
T
T
Greengard
P
P
D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005971:Glutamates / Q000378:metabolism; D008297:Male; D016202:N-Methylaspartate / Q000494:pharmacology; D017072:Neostriatum / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009479:Neuropeptides / Q000502:physiology*; D010750:Phosphoproteins / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012844:Sincalide / Q000502:physiology*
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005971:Glutamates; D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D010750:Phosphoproteins; D001224:Aspartic Acid; D016202:N-Methylaspartate; D012844:Sincalide